Dr. Walker was most recently Chief Medical Officer of Harpoon Therapeutics through its acquisition by Merck in 2024 including leadership over its immune-oncology work. Prior to joining Harpoon ...
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced that its management team will participate in the ...